Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001567619-19-021771

Options or other derivatives

  • Chief Legal Officer acquired 84,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walker Robin A. · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-11-15 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +84,800 $23.32 2029-11-14 84,800 84,800 D
Loading xslF345X03/doc1.xml…